No Data
No Data
Form 144 | Goldman Sachs(GS.US) Director Proposes to Sell 6.02 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 12, $GOLDMAN SACHS GROUP INC PRF 08/05/2037 (S&P GSCI ENH CO TOT RET)(GSCE.US)$、$Goldman Sachs(GS.US)$ Director Montag Thomas K. intends to sell 10,000 shares of its
Form 144 | Goldman Sachs(GS.US) Insider Proposes to Sell 6.02 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Nov 12, $GOLDMAN SACHS GROUP INC PRF 08/05/2037 (S&P GSCI ENH CO TOT RET)(GSCE.US)$、$Goldman Sachs(GS.US)$ Insider Montag Thomas K. intends to sell 10,000 shares of its
Jim Cramer on The Goldman Sachs Group, Inc. (GS): 'You Got My Blessing Though, To Buy Them'
Tuesday Market Finally Slows Down, Takes a Post Veterans Day Breather | Live Stock
3M, UnitedHealth Share Losses Lead Dow's 115-Point Drop
Reuters: Pfizer is exploring the sale of its hospital pharmaceutical business unit
Reuters cited three sources reporting that Pfizer is exploring the sale of its hospital pharmaceutical business. According to the report, Pfizer has hired Goldman Sachs to explore preliminary interest from potential buyers, including private equity firms and other pharmaceutical companies. Sources told Reuters that the deal is not set in stone, and Pfizer may choose to retain the department. Pfizer and Goldman Sachs declined to comment to Reuters.